Granulomatous Inflammation in a Patient with ALK-Negative Anaplastic Large Cell Lymphoma
Main Authors: | Özlem Kandemir Alibakan, Gülşah Keskin, Uğur Yılmaz, Yücel Arman, Esma Evrim Doğan, Evşen Apaydın Arıkan |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2022-02-01
|
Series: | Turkish Journal of Hematology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-93284 |
Similar Items
-
Three years sustained complete remission achieved in a primary refractory ALK-positive anaplastic T large cell lymphoma treated with crizotinib
by: Carolina Valeria Mahuad, et al.
Published: (2016-06-01) -
Discovery and efficacy study of an ALK inhibitor AMX6001 in anaplastic large cell lymphoma Karpas299 mice models
by: Debasis Das, et al.
Published: (2024-12-01) -
Anaplastic lymphoma kinase–positive anaplastic large cell lymphoma presenting as diffuse pulmonary infiltrates
by: Shuku Sato, et al.
Published: (2020-10-01) -
Anaplastic large T-cell lymphoma: 10-year experience at the National Institute of Neoplastic Diseases, Lima – Peru
by: Cristian Pacheco, et al.
Published: (2022-07-01) -
Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma diagnosed in a 90-year-old Japanese woman with simultaneous rearrangements of T-cell receptor and immunoglobulin genes: A case report
by: Kenji Yorita, et al.
Published: (2023-09-01)